Brief: Mangoceuticals Inc Responds To Claims Made By Eli Lilly
21/10/2024 22:42
Oct 21 (Reuters) - Eli Lilly and Co LLY.N :
* RESPONDS TO CLAIMS MADE BY ELI LILLY
* REFUTES ANY AND ALL CLAIMS MADE BY ELI LILLY REGARDING
SALE OF
COMPOUNDED TIRZEPATIDE
Source text for Eikon: ID:nGNX49Qvqm
Further company coverage: LLY.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM